US President Donald Trump came into office vowing to reduce the cost of prescription drugs for the American consumer. But will that relief come at the expense of pharmaceutical balance sheets? We discuss the implications of US policy for pharma companies with Sam Fazeli of Bloomberg Intelligence.


Image Credit: Shutterstock.com

US President Donald Trump came into office vowing to reduce the cost of prescription drugs for the American consumer. But will that relief come at the expense of pharmaceutical balance sheets? We discuss the implications of US policy for pharma companies with Sam Fazeli of Bloomberg Intelligence. Image Credit: <a target="_blank" rel="noopener noreferrer nofollow" href="http://Shutterstock.com">Shutterstock.com</a>

Opinion and analysis of today’s international and local news that matter to Malaysians. Everything you need to know to start and plan your work.

Opinion and analysis of today&rsquo;s international and local news that matter to Malaysians. Everything you need to know to start and plan your work.

Advertisement